Skip to content
Trial Eligibility
Menu

Alzheimer's Disease Clinical Trials near San Francisco, CA

25 studies for Alzheimer's Disease are recruiting at 28 sites within 50 miles of San Francisco, California, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Alzheimer's Disease trials in the US or all trials near San Francisco.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Alzheimer's Disease studies enrolling near San Francisco

Showing 25 studies, nearest first.
  1. Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

    NCT05395624

    • Phase 1/2
    • Ages 18 to 80 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: UCSF (San Francisco, CA); Stanford University (Stanford, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  2. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    NCT06563895

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: University of California, San Francisco (UCSF) (San Francisco, CA); Stanford University (Stanford, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  3. First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia

    NCT05374278

    • Phase 1/2
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: China Basin, UCSF (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  4. [18F]PI-2620 Phase 3 Histopathological Study

    NCT05641688

    • Phase 3
    • Ages 50 years and older
    • Sex: All

    Nearest site: Sutter Health (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  5. Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A

    NCT06932809

    • Early Phase 1
    • Ages 40 to 85 years
    • Sex: All

    Nearest site: University of California (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  6. Alzheimer's Tau Platform: Master Protocol

    NCT06957418

    • Phase 2
    • Ages 50 to 80 years
    • Sex: All

    Nearest site: University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

    NCT07033494

    • Phase 2
    • Ages 50 to 85 years
    • Sex: All

    Nearest site: UCSF Memory and Aging Center ( Site 1031) (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. Remotely-supervised Neuromodulation in PPA

    NCT07260253

    • Interventional
    • Ages 40 years and older
    • Sex: All

    Nearest site: UCSF Memory and Aging Cener (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. CMN LIFU for Enhanced Glymphatic Clearance in Amyloid-Positive MCI

    NCT07866768

    • Interventional
    • Ages 65 years and older
    • Sex: All

    Nearest site: University of California San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

    NCT06847321

    • Phase 2
    • Ages 55 to 80 years
    • Sex: All

    Nearest site: Oakland Clinical Research (Oakland, CA)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    NCT07177352

    • Phase 3
    • Ages 50 to 90 years
    • Sex: All

    Nearest site: Oakland Clinical (Oakland, CA)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

    NCT07688213

    • Phase 2
    • Ages 55 to 85 years
    • Sex: All

    Nearest site: Oakland Clinical- Site Number : 8400010 (Oakland, CA)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

    NCT07717411

    • Phase 3
    • Ages 55 to 80 years
    • Sex: All

    Nearest site: Oakland Clinical (Oakland, CA)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease

    NCT04800588

    • Interventional
    • Ages 18 to 89 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Neurobehavioral Systems, Inc. (Berkeley, CA)

    Distance to nearest recruiting site
    ~10 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    NCT07602582

    • Phase 3
    • Ages 55 years and older
    • Sex: All

    Nearest sites: Infectious Disease Doctors Medical Group, APC (Walnut Creek, CA); Providence Medical Foundation (Santa Rosa, CA)

    Distance to nearest recruiting site
    ~21 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. Senicapoc in Alzheimer's Disease

    NCT04804241

    • Phase 2
    • Ages 55 to 85 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: UC Davis Alzheimer's Disease Center East Bay (Walnut Creek, CA)

    Distance to nearest recruiting site
    ~21 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

    NCT05511363

    • Phase 3
    • Ages 55 to 90 years
    • Sex: All

    Nearest site: Sunwise Clinical Research, LLC - Walnut Creek - IVY - PPDS (Walnut Creek, CA)

    Distance to nearest recruiting site
    ~21 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

    NCT05980949

    • Phase 3
    • Ages 55 to 90 years
    • Sex: All

    Nearest site: Sunwise Clinical Research, LLC - Walnut Creek - IVY - PPDS (Walnut Creek, CA)

    Distance to nearest recruiting site
    ~21 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

    NCT06540833

    • Phase 2
    • Ages 55 years and older
    • Sex: All

    Nearest site: Sunwise Clinical Research (Walnut Creek, CA)

    Distance to nearest recruiting site
    ~21 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

    NCT07011732

    • Phase 3
    • Ages 55 to 90 years
    • Sex: All

    Nearest site: Sunwise Clinical Research (Walnut Creek, CA)

    Distance to nearest recruiting site
    ~21 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

    NCT06976203

    • Phase 3
    • Ages 60 to 85 years
    • Sex: All

    Nearest site: Stanford Neuroscience Health Center (Palo Alto, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease

    NCT07178210

    • Interventional
    • Ages 50 years and older
    • Sex: All

    Nearest site: Stanford Medical Center (Palo Alto, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

    NCT07589595

    • Phase 2
    • Ages 55 to 85 years
    • Sex: All

    Nearest site: Stanford Neuroscience Health Center (Palo Alto, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Bumetanide in Patients With Alzheimer's Disease

    NCT06052163

    • Phase 2
    • Ages 50 to 85 years
    • Sex: All

    Nearest site: Stanford University (Stanford, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. Ultrasonic Debris Clearance to Promote Brain Resilience

    NCT07573982

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford University (Stanford, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining an Alzheimer's Disease clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.